But in NSCLC patients, they are only potent agents to mutant EGFR instead of EGFR T790M, because the suppression of WT EGFR leads to dose-limiting toxicity, such as skin rash/acne, paronychia, and diarrhea [8]. The gene discussed is EGFR; the disease is acne.